Microalbuminuria predicts early mortality and renal disease in non-insulin-dependent
diabetic patients. In insulin-dependent diabetic patients, angiotensin converting enzyme …

OBJECTIVE: To assess if low (1.25 mg) and/or standard (5 mg) doses of the ACE inhibitor
ramipril could prevent progression of microalbuminuria (incipient diabetic nephropathy) in …

The clinical importance of selection of different antihypertensive drugs for the treatment of
diabetic patients is still unclear. Thus we performed a randomised, controlled study in 105 …

The mechanism of action of angiotensin-converting enzyme (ACE) inhibitors on urinary
albumin excretion (UAE) in diabetic patients remains controversial. Sixteen type I, insulin …

Microalbuminuria and proteinuria are strong independent predictors for increased
cardiovascular mortality in non-insulin-dependent diabetic (NIDDM) patients. In such …

Microalbuminuria independently predicts increased cardiovascular risk in hypertensive
patients, especially in those with concomitant diabetes or established cardiovascular …

To investigate the metabolic and renal effects of the nonsulfhydryl, tissue-active ACE
inhibitor quinapril in diabetes and in hypertension, we studied 30 essential hypertensives …

The purpose of this study was to compare the effects of ramipril and nitrendipine on urinary
albumin excretion (UAE) in hypertensive patients with non-insulin-dependent diabetes …

OBJECTIVE—ACE inhibitors delay the progression from incipient to overt diabetic
nephropathy and reduce albumin excretion rate (AER), independently of blood pressure …

It has been demonstrated that antihypertensive treatment of hypertensive diabetic patients is
quite effective in preventing macrovascular and microvascular complications and improving …